Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Hormones for IVF. Photo: Leon Neal/Getty
American women are having only half as many babies as they did 50 years ago, but fertility technology is becoming a bigger and bigger business.
The big picture: The number of babies born per U.S. woman has dropped from 3.58 to 1.89 in the last half century. But women still want help getting pregnant — and answers about their health outside the doctor's office.
So dozens of companies are crowding a market projected to reach $30 billion in annual sales in five years, introducing tracking apps, wearable tech and at-home fertility tests.
- Andreesen Horowitz recently invested in Glow, a company that raised $23 million. Glow makes apps that track menstruation, fertility and pregnancy.
- Union Square Ventures put money in Clue, which makes a competing app and raised $29 million.
- Sequoia led funding for Maven, a virtual women's health clinic.
Other innovators in fertility tech include Meet You, a Chinese fertility tracker app that doubles as a social network; Ava, a wearable device that tracks fertility through physiological metrics like body temperature and breathing rate; and Quanovate, a device that gives real-time feedback on a woman's fertility based on urine samples.
- "There's potential for this area to really grow," says Ja Lee, an analyst at CB Insights. "You have half the population that wants this, but there are not consumer-friendly solutions that are easy to understand."
Between the lines: Many younger women are using these new apps not to pursue pregnancies, but to avoid them, Lee says. "Even if they may not want to have kids ... it gives women info about their general health."
Go deeper: The next generation of fertility treatments